Site Map

Pages

• Annual Report
• News
• News Releases
• Our Customers
  • Consumer Health
• PPD Inc
• Who We Are
  • Company Resources
    • Ethics
    • Events
    • Vendor Resources
      • Purchase Order Requirements
      • Accounts Payable Invoicing
      • Receiving
      • Standard Payment Terms
      • Procurement Mission
    • Legal Notices
      • Cookie Policy
      • Evidera UK England Wales Legal Information
      • PPD UK England Wales Legal Information
      • Privacy Notice for California Residents
        • Contact PPD – CCPA Rights Request
      • French Sunshine Act
      • Modern Slavery Transparency Statement
      • PPD Czech Republic, s.r.o.
      • PPD Italy Srl Legal Information
      • PPD UK Tax Strategy
      • Healthcare Transparency
      • PPD’s French Gender Pay Gap Reports
      • PPD Global Limited Retirement Benefits Engagement Policy Implementation Statement
      • PPD Global Limited Retirement Benefits Scheme Statement of Investment Principles
      • PPD’s UK Gender Pay Gap Reports
        • PPD’s UK Gender Pay Gap Report 2018
        • PPD’s UK Gender Pay Gap Report 2019
        • PPD’s UK Gender Pay Gap Report 2020
        • PPD’s UK Gender Pay Gap Report 2021
        • PPD’s UK Gender Pay Gap Report 2022
    • PPD in the News
    • Privacy Policy
  • Our Mission
    • Accolades
    • Company History
  • OUR 4i VALUES
  • Corporate Responsibility
    • Environmental Stewardship
    • Health Wellness
    • Philanthropy
    • PPD Heroes
  • Locations
    • All Locations
• How We Help
  • Building Patient-Driven Trials
  • Clinical Trial Certainty/Reliability
  • Decentralized Clinical Trials
    • 2020 Clinical Trial Insights Report
    • 2021-2022 Decentralized Clinical Trials Industry Report
    • Capabilities and Solutions
      • DCT Remote Monitoring Article
    • Choosing DCTs
    • Contact Digital Trials
    • DCT Therapeutic Expertise
      • Closing the Gender Gap in Clinical Research
      • DCT Cell Gene Therapy Article
      • Decentralized Clinical Trials Neuroscience Article
      • Decentralized Clinical Trials Oncology Article
      • Increasing Clinical Trial Design Options for Rare Disease Studies
    • DCT Trial Options Changing Respiratory Research
    • Decentralized Clinical Trial Resources
      • Putting Patients First in COVID-19 Research
    • Decentralized Clinical Trials bring research to the patient
    • Decentralized Clinical Trials Survey Report
    • Mobile Clinical Research Sites
    • Modern Strategies for Dermatology Clinical Trials
    • Optimizing Research with Decentralized Strategies
    • The Transformation of Clinical Trial Design and Operations
    • Trials and Tribulations: How Decentralization is Evolving
    • Why PPD DCT
  • Expertise Asia Pacific
    • PPD-SNBL in Japan
      • Employee Retention and Training Programs
      • Yasumasa Kurioka
    • PPD in China
    • PPD®百时益
  • Leveraging Identified Data
  • Proven Delivery of COVID-19 Solutions
    • Gilead
    • Message from PPD CEO
    • Business Continuity
    • COVID-19 Contact
    • WAVE Prediction
    • AES Testimonial
    • COVID-19 experience and expertise resources
  • Supporting Product Approval
  • PPD Biotech
    • Biotech Oncology and Hematology Expertise
  • Ensuring Business Continuity with PPD FSP
  • Moving Medicine Forward Through Pivotal Moments
    • Agility in Pivotal Moments
      • Agility in Pivotal Moments Evolving Clinical Workforce
      • Agility in Pivotal Moments: Decentralized Clinical Trials Post-COVID-19
    • Ingenuity in Pivotal Moments
      • Ingenuity in Pivotal Moments: Diversity in Clinical Trials
    • Stability in Pivotal Moments
      • Stability in Pivotal Moments Real World Data Generated External Comparators
• Our Solutions
  • Clinical Development
    • Early Development
      • EDS Approach to Practical Translational Medicine Article
      • EDS Global Capabilities
      • Phase I
    • Government and Public Health
    • Medical Device Development
    • Peri and Post-Approval
      • Data and Real-World Evidence
      • Evidence Synthesis, Modeling & Communication
      • Interventional Studies
      • Non-Interventional Studies
        • Pregnancy Registries and Infant Follow-up Studies
        • Pregnancy and Lactation Studies
      • Medical Communications
    • Phase II-IV Clinical Trial Management
      • Biostatistics
      • Clinical Trial Monitoring
      • Clinical Data Management
        • Clinical Data Interchange Standards Consortium (CDISC) Experience
      • Global Clinical Supplies
        • New Label Automation System
        • Qualified Person (QP) Release
      • Interactive Response Technology (IRT)
      • Medical Writing
      • Pharmacokinetic and Pharmacodynamic
      • Pharmacovigilance
        • Product Lifecycle
      • Project Management
      • Quality and Enterprise Learning
        • Global Quality and Compliance
          • Good Clinical Practice
        • Enterprise Learning
      • Regulatory Affairs
        • Global Regulatory Affairs
          • Integrated Clinical Development
        • Regulatory Affairs Brochure
        • Contact Regulatory Affairs
        • Regulatory Submission and Publishing Services
        • Chemistry, Manufacturing and Controls (CMC)
          • Pharmacology/ Toxicology
        • Regulatory Consulting and Strategic Intelligence Services
          • Medical Device and Diagnostics Regulatory Expertise
            • Updated Standards for Conducting Medical Device Trials
          • Global Regulatory Medical Writing Services
            • Risk Management & REMS Strategies
    • Functional Service Provider For Clinical Research
      • Clinical Data Management: Past, Present and Future
      • Contact PPD FSP
      • FSP Capacity Management Webinar
      • FSP Onsite Monitoring
      • FSP Resources
      • FSP Trends Report 2022
      • The Importance of an Implementation Lead within FSP Models White Paper
      • The Shift to FSP Outsourcing Webinar
      • FSP Source
    • Site and Patient Centric Solutions
      • Accelerated Enrollment Solutions (AES)
        • Oncology Enrollment Enhancement
      • Enrollment and Site Activation
      • Integrating the Patient Voice
      • Leveraging Technology
      • Reducing Patient Burden
    • Product Development and Consulting
      • Ask Consulting Experts
      • Adaptive Trial Designs
    • Technology
      • Support Systems and Services
      • Information Security
      • To Generate Data and Drive Decisions
        • Preclarus®: Dynamic Visualizations
          • Patient Data Dashboard
          • Preclarus® Sponsor Study Operations Dashboard
          • Preclarus® Scorecard Dashboard
        • Real Time Data
          • More Than Technology
        • Central Lab Database
        • Preclarus®: Innovations
          • Innovations
        • Preclarus®: Resources
          • Video Library
  • PPD Laboratory Services
    • PPD® Laboratories: Part of the COVID-19 Solution
    • Bioanalytical Lab
      • Bioanalytical Biomarker Lab Overview
      • Bioanalytical Laboratory Resources
        • AAV Assay Development and AAV Cell-Based Neutralizing Assay Development
        • Bioanalysis of Oligonucleotides: Ligand Binding and Chromatography
        • Bioanalytical assays for gene therapy programs podcast
        • Bioanalytical Strategies for Oligos
        • Enzymatic Assays
        • Flow Cytometry in Cell and Gene Therapy
        • Molecular Genomics: Selecting qPCR and ddPCR
        • Pre-Existing Antibodies: Considerations for Cell and Gene Therapy Products
      • Bioanalytical Labs Validated Assay List
      • BioA Capabilities
      • BioA Experience and Expertise
        • Bioanalytical Lab Thought Leadership Series
      • Contact Bioanalytical Lab
    • PPD Laboratories Infographics
    • Biomarker Lab
      • Biomarker Laboratory Resources
      • Biomarker Capabilities
      • Contact Biomarker Lab
    • Central Lab
      • Central Laboratory Resources
      • Continuous Development and Flexible Architecture of the Preclarus® Portal
      • Innovative Solutions to Enhance Chain of Custody White Paper
      • PBMC Processing Services
      • PPD Laboratories’ Preclarus Lab Solutions White Paper
      • Preclarus Lab Solutions White Paper
      • Central Lab Capabilities
      • Certifications
      • Contact Central Lab
      • Preclarus
      • Thought Leadership Webinar Series
    • GMP Lab
      • Athlone Lab
      • GMP Lab LC MS Services Article
      • GMP Lab LC MS Services Overview
      • GMP Lab LC MS Services Presentation
      • GMP Laboratory Resources
        • Cell and Gene Therapy Prerequisites
        • Data Automation for Cell and Gene Therapy
        • Extractable and Leachable Testing Methods: Including Special Case Compounds
        • Extractables and Leacheables Compounds – Commonly Used and Detected from Polymer Materials
        • How to Design an Extractables &and Leachables Program Suitable for Your Drug Product
        • New Analytical Tools for Cell and Gene Therapy
        • Overview: Extractables and Leachables Testing
        • Regulatory Considerations for Cell and Gene Therapies
        • Transfer of Bioanalytical Methods to GMP Lab
      • GMP Capabilities
      • GMP Experience and Expertise
      • Contact GMP/CMC Lab
    • Vaccine Sciences Lab
      • Specialized Vaccine Development Capabilities
      • Vaccine Sciences Laboratory Resources
        • Vaccine Immunogenicity Tech Talk Series – Developing a Reliable Method
        • Vaccine Immunogenicity Tech Talk Series – Introduction to Vaccine Immunogenicity
        • Vaccine Immunogenicity Tech Talk Series – Monitoring Assay Performance
        • Vaccine Immunogenicity Tech Talk Series – Operational Optimization
      • Vaccine Lab Capabilities
      • Contact Vaccine Sciences Lab
    • PPD Laboratories FSP
• Therapeutic Areas
  • Biosimilar Development
  • Cell and Gene Therapy Capabilities
    • CAR-T Therapy Podcast
    • Cell Therapy Clinical Trials Report
  • Womens Health
  • Cardiovascular
  • Critical Care
  • Dermatology
    • Dermatology Trials Podcast
  • Gastroenterology
  • Immunology and Rheumatology
  • Infectious Diseases
  • Metabolic and Endocrine
    • Diabetes
    • Rare metabolic disease
  • Neuroscience Research
    • Connect with Our Experts in Rare Neurological Disorders
    • Neurodegenerative Disorders
    • Neuroinflammatory and Other Disorders
    • Psychiatry
    • Rare Neurological Disorders
  • Oncology and Hematology
    • Oncology imperatives early phase
  • Ophthalmology
  • Pediatrics
  • Rare Disease Clinical Trial Therapeutic Research
    • Patient Concierge Service
    • Rare Disease and Pediatric Center of Excellence
    • Committed to Rare Disease Research
    • Neuromuscular
  • Respiratory
  • Urology
  • Vaccine Development
    • mRNA: A New Frontier In Vaccines And Medicine
    • Vaccine Development Videos
  • Nephrology and Renal Diseases
• Participate in a Trial
  • Orlando Clinical Research Unit
  • What to Expect FAQ
  • Austin Clinical Research Unit
    • Volunteer Opportunities
    • Contact Information
    • Online Tour
    • Who can be a volunteer
    • What to Expect
    • Study Volunteer FAQ
  • Las Vegas Clinical Research Unit
    • Volunteer Opportunities
    • Contact Information
    • Who can be a volunteer
    • What to Expect
    • Study Volunteer FAQ
    • Online Tour
  • Phase II-IIIb Clinical Trial Volunteers
  • Become Clinical Trial Investigator
    • Advantages of Being a Clinical Trial Investigator
    • FAQ
    • SiteCoach
    • Process
    • Informed Consent
    • IRB
• Blog
  • Evidence-based Solutions
  • Patient Recruitment
• Contact Us
  • Contact PPD® Digital And Decentralized Solutions
  • Contact vaccine clinical development services
  • Contact Early Development Services
  • Contact Clinical Development Services
  • Contact Peri- and Post-approval Services
  • Contact Quality and Enterprise Learning Services
  • Contact PPD® Laboratory Services
  • Contact PPD Investigator Services
  • Contact PPD Media Relations
  • Contact PPD Webmaster
  • Contact Our Consulting Services
  • Contact Respiratory Services
  • Contact Pharmacovigilance